Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry

Sheila K. Pierson(University of Pittsburgh Medical Center), David C. Fajgenbaum(University of Pennsylvania), Joshua D. Brandstadter(University of Pennsylvania), Ariela Noy(Memorial Sloan Kettering Cancer Center), Makoto Ide(Takamatsu Red Cross Hospital), Daisy Alapat(University of Arkansas Medical Center), Shanmuganathan Chandrakasan(Emory University), Saishravan Shyamsundar(University of Pennsylvania), Megan S. Lim(Memorial Sloan Kettering Cancer Center), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Razelle Kurzrock(Medical College of Wisconsin), Alexander Fosså(Oslo University Hospital), Raymond Wong(Chinese University of Hong Kong), Mateo Sarmiento Bustamante(University of Pennsylvania), Matthew Streetly(King's College - North Carolina), Amy Chadburn(Cornell University), Gordan Srkalović(Regional Cancer Center), Drew A. Torigian(University of Pennsylvania), Mary Jo Lechowicz(Emory University), Corey Casper(University of Washington), Sunita D. Nasta(University of Pennsylvania), Adam Bagg(University of Pennsylvania), Frits van Rhee(Winthrop Rockefeller Foundation), Lu Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Sudipto Mukherjee(Cleveland Clinic), Angela Dispenzieri(Mayo Clinic), Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Éric Oksenhendler(Université Paris Cité)

Blood Advances

February 14, 2025

Cited by 19

Related Papers

|Blood|2022|2.8k

|Molecular Cancer Therapeutics|2017|2.4k

|Molecular Cancer Therapeutics|2015|2.3k

|New England Journal of Medicine|2022|2.2k

|Circulation|2016|2k